Adrafinil
Wakefulness-promoting substance, a prodrug of modafinil that the liver converts, so it acts more slowly; banned in competitive sport.
Pharmacology
Contents
Related comparisons
Adrafinil vs FladrafinilDETAILED OVERVIEW
What is Adrafinil?
Adrafinil is a wakefulness-promoting substance and a prodrug of modafinil: the liver converts it into modafinil, so its effect is similar. It was once approved as a medicine in France for narcolepsy (a sleep disorder), but it was withdrawn from the market in 2011 for commercial reasons. Today it is sold without prescription as a research chemical in the European Union and as a supplement in the United States.
Because it first has to be converted, it starts working more slowly. Headache is a common side effect; it can also cause insomnia and anxiety, and it can moderately raise blood pressure and heart rate. With prolonged use liver enzyme levels can rise, so the risk is higher in liver disease; the official modafinil warning about severe skin reactions applies to adrafinil as well. It is contraindicated in pregnancy and breastfeeding, and it is a doping substance in competitive sport. Few human studies are available.
Mechanism
Modafinil prodrug, alpha-1 adrenergic
Half-life
1 h (Adrafinil) / 12-15 h (Modafinil)
Onset
60-90 min
Legal status
EU OTC research, USA OTC
Anecdotal reports frame Adrafinil as the older prodrug route to Modafinil: the liver must first convert it before anything happens, so the kick-in is slower and smoother, the overall arc longer, and the drop-off gentler. Users who want a "longer, softer Modafinil" describe it positively for exactly that profile.
The trade-offs repeat across reports: conversion is less predictable between individuals, it carries more metabolic baggage, and it is a weak choice when an instant boost is needed – Modafinil itself is the active compound doing the work. Most accounts treat it as a situational, smoother-curve alternative used with deliberate, infrequent timing.
⚠ Not clinical evidence – based on user accounts.
Receptor profile
- Modafinil (active metabolite)Strong
- Dopamine transporterModerate
- Orexin / histamine (wake systems)Moderate
- LiverWeak
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Headache, common and often dose-dependent
- Insomnia and disrupted sleep, especially with late dosing
- Dry mouth, stomach discomfort, nausea
- Anxiety, nervousness, irritability
- Mild blood pressure rise and palpitations
- Elevated liver enzymes (ALT/AST) with prolonged use
- Reduced appetite
Contraindications · 6
- Liver or kidney disease, higher risk due to hepatic conversion to modafinil, monitor LFTs
- Pregnancy and breastfeeding
- Serious cardiovascular disease, arrhythmia, unstable angina, uncontrolled hypertension
- Modafinil hypersensitivity or history of severe skin reaction (Stevens-Johnson, DRESS)
- Reduces hormonal contraceptive efficacy (CYP3A4 induction), use backup method
- Avoid concurrent alcohol and other hepatotoxic drugs
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
FAQ
FAQ
Adrafinil is a substance the liver converts into the well-known wakefulness-promoting drug Modafinil, so its effects are essentially similar to Modafinil's: it helps maintain alertness and concentration, and it was originally developed for narcolepsy-like conditions involving excessive fatigue. Its advantage is that it's available over the counter in some European regions where Modafinil requires a prescription, but the downside is a slower onset since the body first has to convert it.
Telegram
Have a question about Adrafinil?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.